Pfizer to Enter Market for Rare Diseases

Friday, December 4th, 2009

Pfizer has licensed the rights to market a drug for Gaucher disease from an Israeli biotech company.

Genzyme shortages to end soon

Monday, September 28th, 2009

Shortages for Cerezyme and Fabrazyme to end by the first quarter of 2010.

If you're thinking of having children or have a family history of disease, genetic testing can provide vital information.

Your support can lead to remarkable gene discoveries and treatments that fight against genetic diseases.